ArticleOncotarget2020
Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway.
Ashley VanCleave et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it